27 Aug 2024 --- Botanical experts underscore that a decent amount of data exists to address most of the growing safety concerns of ashwagandha (Withania somnifera) among European food safety authorities, over the botanical’s purported use as an abortifacient, indications of an influence on thyroid and immune function and regarding the potential hepatotoxicity, which is only now being assessed. We examine the botanical’s safety record with these experts and explore how to address the ongoing legal scrutiny in Europe. In part two of this three-part series on ashwagandha, Nutrition Insight discusses available data on the botanical’s safety and its potential in addressing regulators’ concerns. In our last installment, we will discuss with two key industry players how the regulatory scrutiny affects the market.
